Search

everythinglearnresearchcommunity

for

Search:↓

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

CCCA and lichen planopilaris have similar histological features, making them hard to distinguish.

CCCA can affect both genders and all ages, and it has a genetic component.

Platelet-Rich Plasma (PRP) can promote new hair growth and increase hair density, but its effectiveness varies depending on the type of hair loss.

Enlarged sweat gland ducts may indicate scarring hair loss.

DNA analysis can help tailor alopecia treatment.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Possible causes of female hair loss include androgenetic alopecia, telogen effluvium, cicatricial alopecia, and alopecia areata incognita; diagnosis and treatment require dermoscopy and histopathology.

848 genes related to fat and metabolism are less active in people with Central Centrifugal Cicatricial Alopecia.

A condition called Central Centrifugal Cicatricial Alopecia causes hair loss and scalp burning in middle-aged African women, and it's treated with various medications, hair transplants, and non-drug methods like wigs.

The document concludes that "hot comb alopecia" is now called "central cicatricial centrifugal alopecia" and its causes are complex.

Trichoscopy is a useful tool for diagnosing different hair and scalp diseases by their unique visual features.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Dermoscopy helps diagnose and monitor treatment for hair loss from scarring conditions like discoid lupus and lichen planopilaris.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Some people experienced hair loss after mesotherapy treatments for hair loss.

Trichoscopy helps diagnose and assess the severity of Frontal Fibrosing Alopecia.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

The updated SALT II tool offers a more precise way to measure scalp hair loss.

Trichoscopy is good for diagnosing and monitoring hair and scalp problems in children but needs more research for certain conditions.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Lichen planopilaris mostly affects women with fair skin and can look different on each person, needing early treatment to prevent hair loss.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.